Skip to content
Screener

Net margin at other companies

Natera, Inc. logo
Natera, Inc.NTRA
-14.6%+0.6pp
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-23%+43.3pp
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-17.8%-2.4pp
Personalis, Inc. logo
Personalis, Inc.PSNL
-148.1%+154pp
NeoGenomics logo
NeoGenomicsNEO
-6.8%-2.4pp
Quest Diagnostics logo
Quest DiagnosticsDGX
9.2%+0.2pp

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$2.08B-31.7%
Enterprise value$2.08B-31.2%
P/S4.7×-3.7×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

Based on trailing twelve months.

The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026. Open the filing →

Filed
May 4, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001818331-26-000041

FAQ

What is GeneDx Holdings's net margin?
GeneDx Holdings (WGS) reported net margin of -17.6% in Q1 2026.
What is the long-term trend for GeneDx Holdings's net margin?
Over 4 years (2020 to 2025), GeneDx Holdings's net margin has grown at a -56.3% compound annual growth rate (CAGR), from -134.6% to -4.9%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about GeneDx Holdings's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude